( NASDAQ-NMS:JAZZ )

News from Jazz Pharmaceuticals plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 14, 2017, 16:05 ET Jazz Pharmaceuticals to Report 2016 Fourth Quarter and Full Year Financial Results on February 28, 2017

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 fourth quarter and full year financial results on Tuesday,...


Feb 08, 2017, 16:05 ET Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating JZP-110 for Excessive Sleepiness in Parkinson's Disease

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110, a...


Jan 17, 2017, 16:02 ET Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating Defibrotide for the Potential Prevention of VOD in High Risk Patients

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 3 clinical trial comparing the...


Jan 03, 2017, 16:05 ET Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 9

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the 35th Annual J.P....


Nov 28, 2016, 16:05 ET Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Study of JZP-110 Evaluating Excessive Sleepiness in Narcolepsy

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that patient enrollment has been completed in its Phase 3 study evaluating JZP-110 in...


Nov 10, 2016, 16:05 ET Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at three upcoming investor...


Nov 08, 2016, 16:05 ET Jazz Pharmaceuticals Announces Third Quarter 2016 Financial Results

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2016 and updated financial guidance for...


Nov 07, 2016, 16:05 ET Jazz Pharmaceuticals to Present New Data at the Annual ASH Meeting

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that eleven abstracts, including four oral presentations, supporting the company's...


Oct 25, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2016 Third Quarter Financial Results on November 8, 2016

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 third quarter financial results on Tuesday, November 8, 2016,...


Oct 03, 2016, 08:30 ET Jazz Pharmaceuticals Initiates Rolling NDA Submission for Vyxeos (CPX-351) Expects to Complete NDA Submission by Early 2017

Jazz Pharmaceuticals plc (Nasdaq; JAZZ) today announced the initiation of a rolling submission of a New Drug Application (NDA) to the United States...


Sep 26, 2016, 16:05 ET Jazz Pharmaceuticals Announces That Patient Enrollment is Complete for the Phase 3 Studies of JZP-110 Evaluating Excessive Sleepiness in Obstructive Sleep Apnea

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that patient enrollment has been completed for its two Phase 3 studies evaluating...


Sep 07, 2016, 16:05 ET Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Morgan Stanley...


Aug 09, 2016, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2016 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the second quarter of 2016 and updated financial guidance for...


Aug 02, 2016, 19:15 ET CMS Grants New Technology Add-On Payment to Defitelio for the Treatment of Hepatic Veno-Occlusive Disease with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States (U.S.) Centers for Medicare and Medicaid Services (CMS)...


Jul 28, 2016, 16:05 ET Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Pfenex Inc. (NYSE MKT: PFNX) today announced an agreement under which Pfenex granted Jazz...


Jul 25, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 second quarter financial results on Tuesday, August 9, 2016,...


Jul 12, 2016, 01:50 ET Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc.

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the results of its tender offer to purchase all of the outstanding shares of common...


Jun 27, 2016, 00:09 ET Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as...


Jun 14, 2016, 16:05 ET Jazz Pharmaceuticals Announces Conference Call and Webcast for JZP-110 Investor Update

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it is hosting an investor conference call and audio webcast on Monday, June 20, 2016...


May 31, 2016, 03:30 ET Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that they have entered into a definitive...


May 18, 2016, 16:05 ET Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming...


May 10, 2016, 16:05 ET Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2016 and updated financial guidance for...


Apr 26, 2016, 16:05 ET Jazz Pharmaceuticals to Report 2016 First Quarter Financial Results on May 10, 2016

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 first quarter financial results on Tuesday, May 10, 2016,...


Feb 23, 2016, 16:05 ET Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2015 Financial Results

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and the fourth quarter of 2015 and provided...


Feb 18, 2016, 09:05 ET Jazz Pharmaceuticals To Present Data From Ongoing Evaluations Of Defibrotide At The 2016 BMT Tandem Meeting

 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that researchers will present three Jazz-sponsored oral abstracts related to the...